- Conditions
- Contraceptive Use
- Interventions
- Conecta Familia, Contraceptive need survey
- Other
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
- Conditions
- Depression, Disability Physical, End Stage Renal Disease, Quality of Life
- Interventions
- CAPABLE Transplant- Open Label Pilot, CAPABLE Transplant- Randomized Control Trial
- Behavioral
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Breast Implant
- Interventions
- Aesthetic Surgery, Silicone gel-filled breast implants - Motiva Implants®
- Other · Device
- Lead sponsor
- Motiva USA LLC
- Industry
- Eligibility
- 22 Years and older · Female only
- Enrollment
- 2,400 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2037
- U.S. locations
- 33
- States / cities
- Beverly Hills, California • Camp Pendleton, California • Los Gatos, California + 26 more
- Conditions
- Traumatic Brain Injury
- Interventions
- Active movement training with limited wearable ankle robot, Ankle/Wrist torque and motion measurement with limited wearable ankle/wrist robot, Gamed-based active movement training with wearable ankle robot, Motor relearning training with wearable ankle robot, Passive movement with limited wearable ankle robot, Passive stretching with wearable ankle robot
- Device
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- 30 Years to 85 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Lung Diseases
- Interventions
- Not listed
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 25 Years to 35 Years
- Enrollment
- 1,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2027
- U.S. locations
- 12
- States / cities
- Birmingham, Alabama • Los Angeles, California • Denver, Colorado + 9 more
- Conditions
- Opioid Use Disorder
- Interventions
- Psilocybin
- Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 21 Years to 70 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2029
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Castration Resistant Metastatic Prostate Cancer
- Interventions
- Enzalutamide, Testosterone cypionate, Testosterone enanthate
- Drug
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Other
- Eligibility
- 18 Years to 90 Years · Male only
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2028
- U.S. locations
- 6
- States / cities
- San Diego, California • Baltimore, Maryland • Boston, Massachusetts + 3 more
- Conditions
- Hypochondroplasia
- Interventions
- Not listed
- Lead sponsor
- QED Therapeutics, a BridgeBio company
- Industry
- Eligibility
- 30 Months to 16 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 8
- States / cities
- Oakland, California • Aurora, Colorado • Washington D.C., District of Columbia + 5 more
- Conditions
- Communication, Pediatric ALL, Respiratory Insufficiency
- Interventions
- HomeVENT decision support tool
- Other
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 600 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2030
- U.S. locations
- 4
- States / cities
- Tampa, Florida • New Orleans, Louisiana • Baltimore, Maryland + 1 more
- Conditions
- Reproductive Health, Sexual Health, Sexually Transmitted Diseases
- Interventions
- Health-E You app
- Other
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 13 Years to 21 Years · Male only
- Enrollment
- 2,752 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2028
- U.S. locations
- 8
- States / cities
- Oakland, California • Washington D.C., District of Columbia • Baltimore, Maryland + 5 more
- Conditions
- Fathers, Mobile Health, Nuclear Family
- Interventions
- text4FATHER
- Behavioral
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 180 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- E-cigarette Use, Withdrawal
- Interventions
- Placebo Nicotine Patch, Transdermal Nicotine Patch
- Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 21 Years to 55 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2028
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Extrapulmonary Neuroendocrine Carcinoma (EP-NEC), Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Carcinomas (NEC), Neuroendocrine Prostate Cancer (NEPC), Small Cell Lung Cancer (SCLC)
- Interventions
- Atezolizumab, Carboplatin + Etoposide, Irinotecan (drug), Lurbinectedin, Paclitaxel., Peluntamig (PT217), Topotecan
- Drug
- Lead sponsor
- Phanes Therapeutics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 203 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2028
- U.S. locations
- 15
- States / cities
- Duarte, California • Los Angeles, California • Denver, Colorado + 11 more
- Conditions
- Abdominal Wound Dehiscence, Anal Fistula, Hidradenitis Suppurativa, Lower Extremity Wound, Necrotizing Soft Tissue Infection, Pilonidal Sinus, Pressure Injury
- Interventions
- Myriad Matrix™ and Myriad Morcells™
- Device
- Lead sponsor
- Aroa Biosurgery Limited
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 800 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2029
- U.S. locations
- 15
- States / cities
- Phoenix, Arizona • Los Angeles, California • Fort Myers, Florida + 11 more
- Conditions
- Prostate Cancer (Adenocarcinoma)
- Interventions
- ADT, Abiraterone, Apalutamide, Darolutamide (BAY 1841788), Docetaxel, Enzalutamide
- Drug
- Lead sponsor
- Canadian Cancer Trials Group
- Network
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 830 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 374
- States / cities
- Anchorage, Alaska • Fairbanks, Alaska • Phoenix, Arizona + 272 more
- Conditions
- Diabetes, Diabetic Foot, Diabetic Foot Ulcer, Peripheral Neuropathy
- Interventions
- Orpyx Sensory Insole System
- Device
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Glaucoma
- Interventions
- Anterior chamber (AC) tube placement, Sulcus tube placement
- Procedure
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 226 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 7
- States / cities
- San Francisco, California • Walnut Creek, California • Miami, Florida + 4 more
- Conditions
- Ovarian Cancer
- Interventions
- Gleolan
- Drug
- Lead sponsor
- NX Development Corp
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 170 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2029
- U.S. locations
- 11
- States / cities
- Phoenix, Arizona • Jacksonville, Florida • Annapolis, Maryland + 8 more
- Conditions
- Periprosthetic Joint Infections
- Interventions
- EP Granules with Tobramycin, empty voids
- Device
- Lead sponsor
- Elute, Inc.
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 204 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2029
- U.S. locations
- 16
- States / cities
- Los Angeles, California • Washington D.C., District of Columbia • Skokie, Illinois + 12 more
- Conditions
- Arrythmia, Cardiomyopathies
- Interventions
- Conventional Management, Intra-Op Prophylactic VT ablation
- Other · Procedure
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 19
- States / cities
- Phoenix, Arizona • Los Angeles, California • San Francisco, California + 15 more
- Conditions
- End Stage Liver Disease
- Interventions
- Not listed
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 5,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2030
- U.S. locations
- 12
- States / cities
- Little Rock, Arkansas • Loma Linda, California • San Francisco, California + 9 more
- Conditions
- Amputation, Amputation, Traumatic, Amputation, Traumatic/Surgery, Congenital Anomaly, Male Genitalia, Penis/Injuries, Penis/Surgery, Penis/Transplantation, Urologic Surgical Procedures, Male, Wounds and Injuries
- Interventions
- Monoclonal Antibody (Humanized Anti-CD52), Penile Allotransplantation, Tacrolimus
- Biological · Procedure · Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years to 69 Years · Male only
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2039
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- HIV, Injectable, Prophylaxis
- Interventions
- Cabotegravir Injectable Suspension (CAB LA)
- Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 19 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- HIV Infections
- Interventions
- Midazolam, Placebo, VH4770359
- Drug
- Lead sponsor
- ViiV Healthcare
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 214 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland